Women’s Health Volume I: The History of Female WellBeing

Stifel

Research

236 Pages

In Volume I, Tim Opler reviews the history of women’s health research and discusses areas where progress has been most significant. He covers endometriosis, menopause, female cancers, operative gynecology and more.

Key Takeaways

Women’s Health Underfunded: Conditions that primarily affect women receive less than ~10% of total biopharma R&D spending, despite women representing roughly half the global population, highlighting a large gap between medical need and research investment.
Endometriosis Underdiagnosed: Endometriosis affects roughly ~10% of women of reproductive age (~190 million globally), yet diagnosis often takes 7–10 years, underscoring a major unmet need for earlier detection and better therapies.
Menopause Market Opportunity: With over 1 billion women expected to be post-menopausal by 2030, demand for treatments addressing menopause symptoms and long-term health effects is poised to expand significantly.

Join our newsletter to have all of this content + Exclusive Newsletter Bonus Content delivered to your inbox every week

Related Content

Scroll to Top